Literature DB >> 25024429

Removal of reprogramming transgenes improves the tissue reconstitution potential of keratinocytes generated from human induced pluripotent stem cells.

Ken Igawa1, Chikara Kokubu2, Kosuke Yusa2, Kyoji Horie2, Yasuhide Yoshimura2, Kaori Yamauchi2, Hirofumi Suemori2, Hiroo Yokozeki2, Masashi Toyoda2, Nobutaka Kiyokawa2, Hajime Okita2, Yoshitaka Miyagawa2, Hidenori Akutsu2, Akihiro Umezawa2, Ichiro Katayama2, Junji Takeda1.   

Abstract

Human induced pluripotent stem cell (hiPSC) lines have a great potential for therapeutics because customized cells and organs can be induced from such cells. Assessment of the residual reprogramming factors after the generation of hiPSC lines is required, but an ideal system has been lacking. Here, we generated hiPSC lines from normal human dermal fibroblasts with piggyBac transposon bearing reprogramming transgenes followed by removal of the transposon by the transposase. Under this condition, we compared the phenotypes of transgene-residual and -free hiPSCs of the same genetic background. The transgene-residual hiPSCs, in which the transcription levels of the reprogramming transgenes were eventually suppressed, were quite similar to the transgene-free hiPSCs in a pluripotent state. However, after differentiation into keratinocytes, clear differences were observed. Morphological, functional, and molecular analyses including single-cell gene expression profiling revealed that keratinocytes from transgene-free hiPSC lines were more similar to normal human keratinocytes than those from transgene-residual hiPSC lines, which may be partly explained by reactivation of residual transgenes upon induction of keratinocyte differentiation. These results suggest that transgene-free hiPSC lines should be chosen for therapeutic purposes. ©AlphaMed Press.

Entities:  

Keywords:  Differentiation; Human; Induced pluripotent stem cell; Keratinocyte; Transgene

Mesh:

Year:  2014        PMID: 25024429      PMCID: PMC4149296          DOI: 10.5966/sctm.2013-0179

Source DB:  PubMed          Journal:  Stem Cells Transl Med        ISSN: 2157-6564            Impact factor:   6.940


  31 in total

1.  Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues.

Authors:  Konrad Hochedlinger; Yasuhiro Yamada; Caroline Beard; Rudolf Jaenisch
Journal:  Cell       Date:  2005-05-06       Impact factor: 41.582

2.  Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice.

Authors:  Sheng Ding; Xiaohui Wu; Gang Li; Min Han; Yuan Zhuang; Tian Xu
Journal:  Cell       Date:  2005-08-12       Impact factor: 41.582

3.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

4.  Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage.

Authors:  Hirofumi Suemori; Kentaro Yasuchika; Kouichi Hasegawa; Tsuyoshi Fujioka; Norihiro Tsuneyoshi; Norio Nakatsuji
Journal:  Biochem Biophys Res Commun       Date:  2006-05-03       Impact factor: 3.575

5.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

6.  Generation of mouse induced pluripotent stem cells without viral vectors.

Authors:  Keisuke Okita; Masato Nakagawa; Hong Hyenjong; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Science       Date:  2008-10-09       Impact factor: 47.728

7.  Generation of germline-competent induced pluripotent stem cells.

Authors:  Keisuke Okita; Tomoko Ichisaka; Shinya Yamanaka
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

Review 8.  Strategies and new developments in the generation of patient-specific pluripotent stem cells.

Authors:  Shinya Yamanaka
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

9.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

Review 10.  Retrovirus-induced oncogenesis and safety of retroviral vectors.

Authors:  Venugopal Nair
Journal:  Curr Opin Mol Ther       Date:  2008-10
View more
  4 in total

1.  Development of a vaccine based on bacteria-mimicking tumor cells coated with novel engineered toll-like receptor 2 ligands.

Authors:  Takashi Akazawa; Toshimitsu Ohashi; Viskam Wijewardana; Kikuya Sugiura; Norimitsu Inoue
Journal:  Cancer Sci       Date:  2018-04-22       Impact factor: 6.716

2.  Generation of targeted homozygosity in the genome of human induced pluripotent stem cells.

Authors:  Yasuhide Yoshimura; Ayako Yamanishi; Tomo Kamitani; Jin-Soo Kim; Junji Takeda
Journal:  PLoS One       Date:  2019-12-05       Impact factor: 3.240

3.  Elimination of Reprogramming Transgenes Facilitates the Differentiation of Induced Pluripotent Stem Cells into Hepatocyte-like Cells and Hepatic Organoids.

Authors:  Jaemin Jeong; Tae Hun Kim; Myounghoi Kim; Yun Kyung Jung; Kyeong Sik Kim; Sehwan Shim; Hyosun Jang; Won Il Jang; Seung Bum Lee; Dongho Choi
Journal:  Biology (Basel)       Date:  2022-03-23

4.  Mesenchymal to Epithelial Transition Induced by Reprogramming Factors Attenuates the Malignancy of Cancer Cells.

Authors:  Mikiro Takaishi; Masahito Tarutani; Junji Takeda; Shigetoshi Sano
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.